Newsroom

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 6 February 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 6 February 2026 Number of Public Shares Purchased: 20...

LONDON--(BUSINESS WIRE)--  09 February 2026 YOUNG & CO.’S BREWERY, P.L.C. Transaction in own shares Young & Co.’s Brewery, P.L.C. (the “Company”) announces that on 06 February 2026, in accordance with the terms of its share buyback programme announced by the Company on 17 November 2025 (the “Share Buyback Programme”), it has purchased the following Non-voting ordinary shares of 12.5 pence each (“Non-voting Shares” and the “Purchased Shares”) in the Company through Peel Hunt LLP (“Peel H...

PARIS--(BUSINESS WIRE)--Regulatory News: Claranova (Paris:CLA) annonce que le transfert de la cotation de ses actions sur le marché réglementé Euronext Paris (Compartiment C) vers le système multilatéral de négociation Euronext Growth Paris sera effectif le 11 février 2026. Claranova pourra ainsi optimiser les coûts liés à sa cotation, tout en bénéficiant de l’attrait d’Euronext Growth, marché de négociation de titres, ouvert aux investisseurs professionnels et particuliers, avec près de 600 so...

PARIS--(BUSINESS WIRE)--Regulatory News: Claranova (Paris:CLA) announces that the transfer of the listing of its shares from the Euronext Paris regulated market (Compartment C) to the Euronext Growth Paris multilateral trading facility will take effect on February 11, 2026. Claranova will thus be able to optimize its listing-related costs while benefiting from the appeal of Euronext Growth, a trading venue open to both professional and retail investors, with nearly 600 listed companies, includi...

TOKYO--(BUSINESS WIRE)--PANECO®, a textile circularity and sustainable materials platform developed by WORKSTUDIO Co., Ltd. (Tokyo, Japan), will exhibit at EuroShop 2026, held in Düsseldorf, Germany. Visitors to EuroShop are actively searching for sustainable materials that can be implemented in commercial spaces and furniture. Across Europe and globally, demand for the practical implementation of sustainable materials is rapidly increasing. In this environment, materials are expected to be not...

TOKYO--(BUSINESS WIRE)--3D Investment Partners Pte. Ltd. (“we”) today submitted its written response to the “Notice on Request to Provide Information on Large-Scale Purchases of Share Certificates, Etc.” which it received from Toho Holdings Co., Ltd. (“Toho HD”) on January 23, 2026. In addition, on January 29, 2026, as we sent a letter to Toho HD’s Nomination and Compensation Committee and outside directors regarding the next CEO nomination process, we hereby publish these materials. We respect...

SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code: “BWLP”) is pleased to announce that it has entered into three-year time charter-out contracts for two of its VLGCs, BW Tucana and BW Yushi. The period charters commenced in January 2026, increasing the fixed-rate time charter-out coverage to approximately 35% of the fleet capacity with an average rate of about USD 43,500 per day for 2026. Due to ongoing negotiations regarding th...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced it has received FDA 510(k) clearance for eyonis® LCS, its AI/ML-powered computer-aided detection and...

BAAR, Switzerland--(BUSINESS WIRE)--Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, « Median » ou « La Société »), développeur d’eyonis®, une suite de logiciels dispositifs médicaux basés sur l’intelligence artificielle (IA) pour le diagnostic précoce des cancers, et un leader pour la fourniture d’analyses d’images par IA et de services centraux d’imagerie pour les essais cliniques en oncologie de l’industrie biopharmaceutique, a annoncé aujourd’hui avoir obt...